BDX

Becton, Dickinson and Company

HALAL

Score: 86/100

stock

Is BDX Halal?

Global medical-technology manufacturer of medical devices, diagnostics, and biosciences instruments — permissible healthcare-equipment business with strong Sharia-compliance profile.

What You Should Know

Becton, Dickinson and Company (BD) is one of the world's largest medical-technology companies, organized into three reporting segments: BD Medical (the largest segment, including syringes and needles, medication-management systems such as the Pyxis automated dispensing platform and the Alaris infusion-pump system, prefillable drug-delivery systems for pharmaceutical partners, and diabetes-care products), BD Life Sciences (specimen-collection products including the iconic Vacutainer blood-collection system, integrated diagnostic instruments and reagents for infectious-disease and other testing, and flow-cytometry and research instruments for the biosciences market), and BD Interventional (surgical and peripheral-intervention products, urology and critical-care products, and the Bard portfolio acquired in 2017 including vascular, oncology, and surgical-specialty devices). Medical-device, diagnostics, and life-sciences-instrument manufacturing is unambiguously permissible at the activity level under standard Sharia methodology — BD's products serve essential healthcare needs. The financial screen consideration is leverage: BD took on substantial debt to fund the 2017 C. R. Bard acquisition and has been deleveraging through free cash flow generation; the consolidated debt-to-market-cap ratio sits in a manageable range that should be verified against the 33% Sharia threshold at the time of investment. Most major Sharia advisory boards classify Becton Dickinson as permissible with purification of small interest-income components.

⚠️ Concerns

•Debt-to-market-cap ratio has been elevated by the 2017 C. R. Bard acquisition financing — BD has been deleveraging through free cash flow; verify against the 33% Sharia threshold at the time of investment
•Minor interest income on cash and short-term investment balances — purification of a small portion of dividends may be advisable
•Some BD products are used in medical procedures or research that individual investors may wish to evaluate on ethical grounds; this is generally not flagged at the corporate-Sharia-screen level given the essential-healthcare context
•BD announced plans to separate its Biosciences and Diagnostic Solutions business — verify the current corporate structure at the time of investment
•Substantial dividend — Becton Dickinson is a Dividend Aristocrat with multi-decade dividend increases; consult your preferred screening platform for the exact purification percentage in the relevant period